Results 241 to 250 of about 162,657 (334)

Efficacy of ciclosporin monotherapy in non‐severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study

open access: yesBritish Journal of Haematology, EarlyView.
Summary The efficacy of ciclosporin (CsA) to treat transfusion‐independent non‐severe aplastic anaemia (TI‐NSAA) has not yet been systematically evaluated. We conducted a prospective trial in patients with TI‐NSAA treated with CsA monotherapy. CsA (3.5 mg/kg/day) was administered to patients with TI‐NSAA aged ≥16.
Ken Ishiyama   +14 more
wiley   +1 more source

Karyotype analysis of Quasipaa spinosa David, 1875 (Anura, Dicroglossidae) with conventional cytogenetic techniques [PDF]

open access: gold
Liaoruilin Zhang   +6 more
openalex   +1 more source

The Danish Turner Syndrome Cryopreservation study: PROTOCOL for a prospective cohort Study on reproductive outcomes after ovarian tissue cryopreservation in girls with Turner syndrome. [PDF]

open access: yesOrphanet J Rare Dis
Balle CM   +15 more
europepmc   +1 more source

Improved outcomes in elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol—A prospective study

open access: yesBritish Journal of Haematology, EarlyView.
In this population‐based study the relapse rates were remarkably low in patients reaching day 79 with active treatment, challenging the widely accepted belief that ALL is difficult to cure in the elderly. Summary Population data have shown that the prognosis for elderly patients with acute lymphoblastic leukaemia (ALL) is poor, even in the modern era ...
P. Quist‐Paulsen   +8 more
wiley   +1 more source

Hypogonadotropic Hypogonadism in a Central Obesity Patient with 46, XY, t(1; 10)(q42; q24). [PDF]

open access: yesJBRA Assist Reprod
Luo H   +7 more
europepmc   +1 more source

Efficacy of MRD-triggered anti-CD20 retreatment in patients with high-risk chronic lymphocytic leukemia: a case series. [PDF]

open access: yesBlood Adv
Goergen E   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy